GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Memphasys MEM.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.00

0.00%

Close of 5 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Memphasys — daily ASX:MEM

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Memphasys on TradingView ↗
Market value
A$14.1m
Last close × shares
Volume
350.1k
Shares, 5 Nov 2026

About Memphasys

Its shares trade on ASX under the ticker MEM.AX. It has been listed since 14 May 2007. In the fiscal year to 30 June 2026, it reported revenue of A$273,793 and a net loss of A$4.1m. At that date it held total assets of A$11.2m and shareholders' equity of A$4.2m.

Memphasys Ltd. is a life sciences company. The company is headquartered in Homebush West, New South Wales. The company went IPO on 2007-05-14. The firm is engaged in developing novel medical devices, diagnostics, and media with applications to assisted reproduction technology (ART) in humans and animals. Its reproductive biotechnology products in development include medical devices, in vitro diagnostics, and new proprietary media. The firm's product pipeline includes Felix, ROSA, and AI-Port. The Felix is a patented, automated device for quickly separating high quality sperm from semen for use in human in vitro fertilization (IVF) procedures without causing damage to DNA. Felix has a sizable target market worldwide. The Company’s ROSA is an in vitro diagnostic that assesses semen and blood samples for the presence of oxidative stress. The AI-Port stores and transports animal semen for artificial insemination (AI) for up to four days without the harmful effects of freezing sperm used in standard AI procedures in livestock.

Figures and description from our data supplier, not checked against the company's own report.

More about Memphasys →

Latest on Memphasys

Our reporting

We have not reported on Memphasys yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Memphasys's ticker?

Memphasys trades as MEM.AX on ASX, under ISIN AU000000MEM5.

What was Memphasys's last closing price?

0.00 on 5 Nov 2026. The figure is in AUD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.